Lot-to-lot consistency study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants from 2 Months of Age

Trial Identifier: PSK00029
Sponsor: Sanofi
Start Date: January 2026
Primary Completion Date: June 2027
Study Completion Date: May 2028
Condition: Pneumococcal Immunisation; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
HONDURAS San Pedro Sula, HONDURAS, 21104
HONDURAS Tegucigalpa, HONDURAS, 11101
United States, Florida Tampa, Florida, United States, 33613
UNITED STATES, Michigan Allen Park, Michigan, UNITED STATES, 48101
UNITED STATES, South Carolina Charleston, South Carolina, UNITED STATES, 29407